HDMA Commends Congressional Enactment Of Food And Drug Administration Amendments Act (H.R. 3580)

Main Category: Regulatory Affairs / Drug Approvals
Also Included In: Public Health
Article Date: 26 Sep 2007 - 14:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:5 stars

5 (1 votes)


HDMA commends the U.S. House of Representatives and the Senate for passing the Food and Drug Administration Amendments Act (H.R. 3580), which includes important provisions to enhance patient safety. HDMA is also pleased that new authority has been provided to the FDA to establish standards for numerical identifiers that will facilitate the tracking and tracking of prescription medicines.

"Patient safety is the first priority of our primary distributor members. As such, it is critical that manufacturers, distributors and pharmacies continue to work together and with the government to develop consistent systems that support the unique identification, tracking and tracing of products throughout the supply chain," said HDMA President and CEO John M. Gray. "HDMA has been working for many years to encourage the implementation of effective track-and-trace systems to monitor, protect and enhance our secure supply chain against increasingly sophisticated criminals who may try to introduce counterfeit or diverted drugs into the legitimate supply chain."

HDMA members have worked with supply chain partners to conduct pilot programs and case studies to evaluate the most effective track-and-trace technologies. To encourage adoption of these technologies, HDMA will continue to support these efforts, as well as spearhead broad-based task forces with industry and government leaders to explore innovative business, policy and technology solutions that advance safety, security and efficiency.

About HDMA

The Healthcare Distribution Management Association (HDMA) and its members are committed to patient safety by delivering life-saving health products and services through a secure and efficient healthcare distribution system. These primary, full-service healthcare distributors are responsible for ensuring that billions of units of medication are safely delivered -- to tens of thousands of retail pharmacies, nursing homes, clinics and providers -- in all 50 states. HDMA and its members are the vital link in the healthcare system that is responsible for medicine safety, quality, integrity and availability in the marketplace. Through leadership on public policy and industry best practices, HDMA and its members focus on providing value, removing costs and developing innovative solutions to deliver care safely and effectively. http://www.HealthcareDistribution.org

Article adapted by Medical News Today from original press release.
Visit our regulatory affairs / drug approvals section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Healthcare Distribution Management Association. "HDMA Commends Congressional Enactment Of Food And Drug Administration Amendments Act (H.R. 3580)." Medical News Today. MediLexicon, Intl., 26 Sep. 2007. Web.
9 Feb. 2012. <http://www.medicalnewstoday.com/releases/83608.php>

APA
Healthcare Distribution Management Association. (2007, September 26). "HDMA Commends Congressional Enactment Of Food And Drug Administration Amendments Act (H.R. 3580)." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/83608.php.

Please note: If no author information is provided, the source is cited instead.


Regulatory Affairs / Drug Approvals

Most Popular Articles



Follow Our Regulatory Affairs News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Regulatory Affairs / Drug Approvals Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »